Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 37.58B |
| Enterprise value | 36.29B |
| Trailing P/E | 26.10 |
| Forward P/E | 22.88 |
| PEG ratio (5-yr expected) | 3.09 |
| Price/sales (ttm) | 6.58 |
| Price/book (mrq) | 5.05 |
| Enterprise value/revenue | 6.31 |
| Enterprise value/EBITDA | 24.65 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.11 |
| 52-week change 3 | -24.00% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 96.12 |
| 52-week low 3 | 58.93 |
| 50-day moving average 3 | 88.01 |
| 200-day moving average 3 | 81.53 |
Share statistics
| Avg vol (3-month) 3 | 3.67M |
| Avg vol (10-day) 3 | 8.73M |
| Shares outstanding 5 | 602.6M |
| Implied shares outstanding 6 | 877.66M |
| Float 8 | 596.1M |
| % held by insiders 1 | 0.89% |
| % held by institutions 1 | 84.71% |
| Shares short (15 Jul 2024) 4 | 7.7M |
| Short ratio (15 Jul 2024) 4 | 2.28 |
| Short % of float (15 Jul 2024) 4 | 1.29% |
| Short % of shares outstanding (15 Jul 2024) 4 | 1.28% |
| Shares short (prior month 14 Jun 2024) 4 | 8.19M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 01 Jun 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 30 Jun 2024 |
Profitability
| Profit margin | 23.74% |
| Operating margin (ttm) | 27.22% |
Management effectiveness
| Return on assets (ttm) | 12.28% |
| Return on equity (ttm) | 22.02% |
Income statement
| Revenue (ttm) | 6.2B |
| Revenue per share (ttm) | 10.27 |
| Quarterly revenue growth (yoy) | -9.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 2.03B |
| Net income avi to common (ttm) | 1.54B |
| Diluted EPS (ttm) | 2.39 |
| Quarterly earnings growth (yoy) | 19.30% |
Balance sheet
| Total cash (mrq) | 1.99B |
| Total cash per share (mrq) | 3.31 |
| Total debt (mrq) | 693M |
| Total debt/equity (mrq) | 9.23% |
| Current ratio (mrq) | 3.71 |
| Book value per share (mrq) | 12.35 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.